Niagen Bioscience Statistics
Total Valuation
NAGE has a market cap or net worth of $287.32 million. The enterprise value is $229.09 million.
| Market Cap | 287.32M |
| Enterprise Value | 229.09M |
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NAGE has 79.81 million shares outstanding. The number of shares has increased by 7.04% in one year.
| Current Share Class | 79.81M |
| Shares Outstanding | 79.81M |
| Shares Change (YoY) | +7.04% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 29.53% |
| Owned by Institutions (%) | 46.28% |
| Float | 52.43M |
Valuation Ratios
The trailing PE ratio is 17.47 and the forward PE ratio is 17.59.
| PE Ratio | 17.47 |
| Forward PE | 17.59 |
| PS Ratio | 2.25 |
| Forward PS | 1.94 |
| PB Ratio | 3.55 |
| P/TBV Ratio | 3.81 |
| P/FCF Ratio | 71.34 |
| P/OCF Ratio | 66.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.12, with an EV/FCF ratio of 55.79.
| EV / Earnings | 12.29 |
| EV / Sales | 1.76 |
| EV / EBITDA | 19.12 |
| EV / EBIT | 20.64 |
| EV / FCF | 55.79 |
Financial Position
The company has a current ratio of 4.61, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.61 |
| Quick Ratio | 3.48 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.19 |
| Debt / FCF | 0.63 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 27.07% and return on invested capital (ROIC) is 63.23%.
| Return on Equity (ROE) | 27.07% |
| Return on Assets (ROA) | 7.09% |
| Return on Invested Capital (ROIC) | 63.23% |
| Return on Capital Employed (ROCE) | 12.13% |
| Weighted Average Cost of Capital (WACC) | 16.06% |
| Revenue Per Employee | $1.11M |
| Profits Per Employee | $159,291 |
| Employee Count | 117 |
| Asset Turnover | 1.33 |
| Inventory Turnover | 2.65 |
Taxes
In the past 12 months, NAGE has paid $1.06 million in taxes.
| Income Tax | 1.06M |
| Effective Tax Rate | 5.38% |
Stock Price Statistics
The stock price has decreased by -66.48% in the last 52 weeks. The beta is 2.17, so NAGE's price volatility has been higher than the market average.
| Beta (5Y) | 2.17 |
| 52-Week Price Change | -66.48% |
| 50-Day Moving Average | 4.55 |
| 200-Day Moving Average | 6.63 |
| Relative Strength Index (RSI) | 29.87 |
| Average Volume (20 Days) | 1,023,014 |
Short Selling Information
The latest short interest is 5.40 million, so 6.77% of the outstanding shares have been sold short.
| Short Interest | 5.40M |
| Short Previous Month | 5.45M |
| Short % of Shares Out | 6.77% |
| Short % of Float | 10.30% |
| Short Ratio (days to cover) | 8.12 |
Income Statement
In the last 12 months, NAGE had revenue of $130.42 million and earned $18.64 million in profits. Earnings per share was $0.21.
| Revenue | 130.42M |
| Gross Profit | 83.83M |
| Operating Income | 11.10M |
| Pretax Income | 19.70M |
| Net Income | 18.64M |
| EBITDA | 11.98M |
| EBIT | 11.10M |
| Earnings Per Share (EPS) | $0.21 |
Balance Sheet
The company has $66.40 million in cash and $2.58 million in debt, with a net cash position of $63.82 million or $0.80 per share.
| Cash & Cash Equivalents | 66.40M |
| Total Debt | 2.58M |
| Net Cash | 63.82M |
| Net Cash Per Share | $0.80 |
| Equity (Book Value) | 82.33M |
| Book Value Per Share | 1.03 |
| Working Capital | 82.30M |
Cash Flow
In the last 12 months, operating cash flow was $4.43 million and capital expenditures -$321,000, giving a free cash flow of $4.11 million.
| Operating Cash Flow | 4.43M |
| Capital Expenditures | -321,000 |
| Depreciation & Amortization | 881,000 |
| Net Borrowing | -9,000 |
| Free Cash Flow | 4.11M |
| FCF Per Share | $0.05 |
Margins
Gross margin is 64.28%, with operating and profit margins of 8.51% and 14.29%.
| Gross Margin | 64.28% |
| Operating Margin | 8.51% |
| Pretax Margin | 15.10% |
| Profit Margin | 14.29% |
| EBITDA Margin | 9.19% |
| EBIT Margin | 8.51% |
| FCF Margin | 3.15% |
Dividends & Yields
NAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.04% |
| Shareholder Yield | -7.04% |
| Earnings Yield | 6.36% |
| FCF Yield | 1.40% |
Analyst Forecast
The average price target for NAGE is $12.60, which is 250.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.60 |
| Price Target Difference | 250.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 13, 2016. It was a reverse split with a ratio of 1:3.
| Last Split Date | Apr 13, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
NAGE has an Altman Z-Score of 12.45 and a Piotroski F-Score of 5.
| Altman Z-Score | 12.45 |
| Piotroski F-Score | 5 |